Key result
Immunization with a synthetic foot-and-mouth disease virus peptide conjugated to gold nanoparticles and complete Freund's adjuvant significantly increased antibody titers compared to a commercial vaccine.
Why the study?
Does a synthetic foot-and-mouth disease virus peptide conjugated to gold nanoparticles enhance immunological response in guinea pigs?
Does a synthetic foot-and-mouth disease virus peptide conjugated to gold nanoparticles enhance immunological response in guinea pigs?
Absolute Event Rate: 32768% vs 512%
p-value: p=0.00045
Gold nanoparticles can serve as an effective antigen carrier and adjuvant to enhance the immune response to a synthetic foot-and-mouth disease virus peptide in guinea pigs.
Caution against adoption in animals; hypothesis-generating for gold nanoparticle adjuvants in FMDV vaccines.
Foot-and-mouth disease is an acute, highly contagious infection of domestic and wild cloven-hoofed animals, which can be transmitted to humans. In many cases, the existing vaccines are not quite effective. The purpose of this study was to test the possibility of using gold nanoparticles as an antigen carrier and an adjuvant. The immunogenic properties of gold nanoparticles were assessed by conjugating the particles to a synthetic peptide of the VP1 capsid protein of the foot-and-mouth disease virus. The resulting conjugate (with or without the use of complete Freund’s adjuvant), a commercial vaccine, and the native peptide served to immunize guinea pigs. The titer and sensitivity of the raised antibodies were maximal for the combination comprising the nanoparticle–peptide conjugate and complete Freund’s adjuvant. Antibody biosynthesis was accompanied by increased production of proinflammatory cytokines (especially IFN-γ) and by stimulation of the respiratory activity of peritoneal macrophages. The use of gold nanoparticles as a hapten carrier enhanced the immune response even when complete Freund’s adjuvant was not used.
No takes yet. Share an insight, caveat, or question.
Дыкман et al. (2015) studied Foot-and-mouth disease (vaccine development) (n=15). AuNP-peptide conjugate with complete Freund's adjuvant vs. Commercial FMD vaccine was evaluated on Antibody titer in blood sera 10 days after twofold immunization (p=0.00045). Immunization with a synthetic foot-and-mouth disease virus peptide conjugated to gold nanoparticles and complete Freund's adjuvant significantly increased antibody titers compared to a commercial vaccine.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: